Almirall Partners with CrystalO to Discover Novel Dermatology Drugs
Barcelona, Spain, August 9, 2026 Almirall announced a collaboration and licensing agreement with CrystalO, a China-based biotechnology company, to...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Barcelona, Spain, August 9, 2026 Almirall announced a collaboration and licensing agreement with CrystalO, a China-based biotechnology company, to...
Boston, MA, August 9, 2026 Asimov announced the successful completion of a cell line development campaign in collaboration with...
BAD HOMBURG, Germany, July 31, 2026 Fresenius Kabi, an operating company of Fresenius, announced that both the U.S. Food...
ROTKREUZ, Switzerland, July 31, 2026 Polpharma Biologics International AG announced that the U.S. Food and Drug Administration (FDA) and...
INCHEON, South Korea & NASHVILLE, Tenn., July 20, 2026 Samsung Bioepis Co., Ltd. and Harrow, Inc. have presented positive...
NASHVILLE, Tenn., July 20, 2026 Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America,...
TEL AVIV, Israel / ZUG, Switzerland | July 9, 2026 Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical...
RALEIGH, N.C. | July 9, 2026 Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, has announced that the...
REYKJAVIK, Iceland, June 8, 2026 Alvotech announced that the U.S. Food and Drug Administration (FDA) has accepted for review...
Mumbai, India and Naples, Florida, June 5, 2026 Global pharmaceutical company Lupin Limited has secured a major regulatory milestone...
